Want to see VTGN full AI Analyst Report?
Fasedienol Nasal Spray - Fasedienol Nasal Spray
Social Anxiety Disorder
Phase II
Recruiting
A Clinical Trial to Assess the Efficacy, Safety, and Tolerability of a Repeat Dose of Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder
Jan 29, 2025
―
Fasedienol Nasal Spray
Social Anxiety Disorder (Sad)
Phase III
Recruiting
Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-4)
Sep 24, 2024
―
Fasedienol Nasal Spray
Social Anxiety Disorder
Phase III
Recruiting
Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-3)
Apr 04, 2024
―
Ph94b
Social Anxiety Disorder
Phase III
Terminated
Open-label Safety Trial of PH94B in Social Anxiety Disorder (SAD)
Aug 26, 2021
―
Ph94b Nasal Spray
Social Anxiety Disorder
Phase III
Completed
PH94B Nasal Spray for Anxiety Induced by a Public Speaking Challenge
Feb 10, 2021
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does VistaGen Therapeutics (VTGN) have in its pipeline
VTGN is currently developing the following drugs: Fasedienol Nasal Spray - Fasedienol Nasal Spray, Fasedienol Nasal Spray, Fasedienol Nasal Spray. These drug candidates are in various stages of clinical development as the company works toward FDA approval.